<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="156485">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02021292</url>
  </required_header>
  <id_info>
    <org_study_id>AC-055E201</org_study_id>
    <nct_id>NCT02021292</nct_id>
  </id_info>
  <brief_title>MERIT-1: Macitentan in thE tReatment of Inoperable Chronic Thromboembolic Pulmonary Hypertension</brief_title>
  <acronym>MERIT-1</acronym>
  <official_title>Prospective, Randomized, Placebo-controlled, Double-blind, Multicenter, Parallel-group, 24-week Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Actelion</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Actelion</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <authority>Austria: Agency for Health and Food Safety</authority>
    <authority>Belgium: The Federal Public Service (FPS) Health, Food Chain Safety and Environment</authority>
    <authority>Bulgaria: Bulgarian Drug Agency</authority>
    <authority>Canada: Health Canada</authority>
    <authority>Chile: Instituto de Salud Pública de Chile</authority>
    <authority>China: Food and Drug Administration</authority>
    <authority>Czech Republic: State Institute for Drug Control</authority>
    <authority>France: Agence Nationale de Sécurité du Médicament et des produits de santé</authority>
    <authority>Germany: Federal Institute for Drugs and Medical Devices</authority>
    <authority>Hungary: National Institute for Quality and Organizational Development in Healthcare and Medicines</authority>
    <authority>Italy: The Italian Medicines Agency</authority>
    <authority>Mexico: Federal Commission for Sanitary Risks Protection</authority>
    <authority>Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)</authority>
    <authority>Poland: Office for Registration of Medicinal Products, Medical Devices and Biocidal Products</authority>
    <authority>Russia: FSI Scientific Center of Expertise of Medical Application</authority>
    <authority>Russia: Ministry of Health of the Russian Federation</authority>
    <authority>South Africa: Medicines Control Council</authority>
    <authority>Switzerland: Swissmedic</authority>
    <authority>Thailand: Food and Drug Administration</authority>
    <authority>United Kingdom: Medicines and Healthcare Products Regulatory Agency</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Study to evaluate if macitentan is efficient, safe and tolerable enough to be used for
      treatment of inoperable chronic thromboembolic pulmonary hypertension (CTEPH).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2014</start_date>
  <completion_date type="Anticipated">October 2015</completion_date>
  <primary_completion_date type="Anticipated">September 2015</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>PVR at rest at Week 16 expressed as percent of baseline PVR at rest</measure>
    <time_frame>baseline to Week 16</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from baseline to Week 24 in exercise capacity, as measured by the 6MWD.</measure>
    <time_frame>baseline to Week 24</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline to Week 24 in Borg dyspnea index collected at the end of the 6MWT.</measure>
    <time_frame>baseline to Week 24</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of subjects with worsening in WHO FC from baseline to Week 24</measure>
    <time_frame>baseline to Week 24</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">78</enrollment>
  <condition>Chronic Thromboembolic Pulmonary Hypertension (CTEPH)</condition>
  <arm_group>
    <arm_group_label>Macitentan</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Macitentan 10 mg, oral tablet, to be taken once daily.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Matching placebo oral tablet, to be taken once daily.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Macitentan</intervention_name>
    <description>Macitentan 10 mg, oral tablet, to be taken once daily.</description>
    <arm_group_label>Macitentan</arm_group_label>
    <other_name>ACT-064992</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Matching placebo oral tablet, to be taken once daily.</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or female &gt;= 18 and &lt;= 80 years of age.

          -  Subject with CTEPH (WHO Group 4) judged as inoperable due to the localization of the
             obstruction being surgically inaccessible (i.e., distal disease).

        Exclusion Criteria:

          -  Previous pulmonary endarterectomy.

          -  Recurrent thromboembolism despite sufficient oral anticoagulants.

          -  Symptomatic acute pulmonary embolism in the 6-month period prior to randomization.

          -  Known moderate-to-severe restrictive lung disease (i.e., TLC &lt; 60% of predicted
             value) or obstructive lung disease (i.e., FEV1 &lt; 70% of predicted, with FEV1/FVC &lt;
             65%) or known significant chronic lung disease diagnosed by chest imaging (e.g.,
             interstitial lung disease, emphysema).

          -  Acute or chronic conditions (other than dyspnea) that limit the ability to comply
             with study requirements in the 3-month period prior to Screening visit or during the
             Screening period.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of California - San Diego</name>
      <address>
        <city>La Jolla</city>
        <state>California</state>
        <zip>92093</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Kim Kerr</last_name>
      <phone>858-657-7140</phone>
      <email>kmkerr@AD.ucsd.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kentuckiana Pulmonary Associates</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John McConnell</last_name>
      <phone>502-587-8000</phone>
      <email>mcco3526@bellsouth.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Medical University of Innsbruck Div. of Clinical and Internal Medicine, Pulmonology</name>
      <address>
        <city>Innsbruck</city>
        <country>Austria</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Christian Kähler</last_name>
      <phone>0043-512-504 232 67</phone>
      <email>christian.kaehler@uki.at</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Medical University of Vienna and AKH Cardiology</name>
      <address>
        <city>Vienna</city>
        <country>Austria</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Irene Lang</last_name>
      <phone>+ 43 1 40 400 49 65</phone>
      <email>irene.lang@meduniwien.ac.at</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital Gasthuisberg / Interne Geneeskunde - I.G. Pneumologie</name>
      <address>
        <city>Leuven</city>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Marion Delcroix</last_name>
      <phone>+32 16 34 68 33</phone>
      <email>marion.delcroix@uzleuven.be</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>London Health Sciences Centre / The Univ. of Western Ontario</name>
      <address>
        <city>London</city>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sanjay Mehta</last_name>
      <phone>519-667-6723</phone>
      <email>sanjay.mehta@lhsc.on.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Health Sciences Center</name>
      <address>
        <city>Winnipeg</city>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Zoheir Bshouty</last_name>
      <phone>204-787-1059</phone>
      <email>zbshouty@hsc.mb.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinica Tabancura - Cardiology Unit</name>
      <address>
        <city>Santiago</city>
        <country>Chile</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Pablo Sepulveda Varela</last_name>
      <phone>562-23954364</phone>
      <email>pablosep@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre for PPH, Charles University , II Interni klinika1.LF a VFN</name>
      <address>
        <city>Praha</city>
        <country>Czech Republic</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Pavel Jansa</last_name>
      <phone>+ 420 224 962 365</phone>
      <email>jansapavel@yahoo.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Grenoble Hôpital Michallon</name>
      <address>
        <city>Grenoble</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hélène Bouvaist</last_name>
      <phone>+33 4 76 76 76 78</phone>
      <email>HBouvaist@chu-grenoble.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de Bicêtre</name>
      <address>
        <city>Le Kremlin-Bicêtre cedex</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Xavier Jais</last_name>
      <phone>+33 1 45 21 78 95</phone>
      <email>xavier.jais@bct.aphp.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de Toulouse Hopital Larrey</name>
      <address>
        <city>Toulouse Cedex 9</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Grégoire Prévot</last_name>
      <phone>+ 33 5 67 77 17 09</phone>
      <email>prevot.g@chu-toulouse.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Justus-Liebig-Universität Gießen</name>
      <address>
        <city>Giessen</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ardeschir Ghofrani</last_name>
      <phone>+49 641 99 42422</phone>
      <email>ardeschir.ghofrani@innere.med.uni-giessen.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Thoraxklinik am Universitätsklinikum Heidelberg</name>
      <address>
        <city>Heidelberg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ekkehard Grünig</last_name>
      <phone>0049 6221 396 8053</phone>
      <email>ekkehard.gruenig@med.uni-heidelberg.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätskliniken des Saarlandes / Medizinische Klinik und Poliklinik, Innere Medizin V</name>
      <address>
        <city>Homburg/Saar</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Heinrike Wilkens</last_name>
      <phone>+49 6841 1623619</phone>
      <email>heinrike.wilkens@uniklinik-saarland.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Köln Herzzentrum / Klinik III für Innere Medizin</name>
      <address>
        <city>Köln</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Stephan Rosenkranz</last_name>
      <phone>+49 221 478 32 402</phone>
      <email>Stephan.Rosenkranz@uk-koeln.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Missionsärztliche Klinik gGmbH Akademisches Lehrkrankenhaus der Julius-Maximilians-Universität</name>
      <address>
        <city>Würzburg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matthias Held</last_name>
      <phone>+499317912811</phone>
      <email>matthias.held@missioklinik.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Gottsegen György Országos Kardiológiai Intézet</name>
      <address>
        <city>Budapest</city>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>András Temesvári</last_name>
      <phone>+36 1 215 1220</phone>
      <email>temesvari.andras00@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Semmelweis Egyetem</name>
      <address>
        <city>Budapest</city>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Kristóf Karlócai</last_name>
      <phone>+36 1355 97 33</phone>
      <phone_ext>7018</phone_ext>
      <email>kristof@karlocai.hu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Debreceni Egyetem Orvos- és Egészségtudományi Centrum, Kardiológiai Klinika</name>
      <address>
        <city>Debrecen</city>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Istvan Edes</last_name>
      <phone>+36 (52) 414928</phone>
      <email>edes@dote.hu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Instituto Nacional de Cardiologia (INC) Ignacio Chavez</name>
      <address>
        <city>Mexico City</city>
        <country>Mexico</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Tomas Rene Pulido Zamudio</last_name>
      <phone>52-55-5573-2911</phone>
      <phone_ext>1355</phone_ext>
      <email>tpulido@prodigy.net.mx</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>VU Medisch Centrum / Afdeling longziekten</name>
      <address>
        <city>Amsterdam</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Anton Vonk-Noordegraaf</last_name>
      <phone>+31 20 44 44444</phone>
      <email>A.Vonk@vumc.nl</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Wojewódzki Specjalistyczny Szpital im. dr Wadysawa Biegaskiego</name>
      <address>
        <city>Lodzi</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jaroslaw Kasprzak</last_name>
      <phone>+48 42 251 60 75</phone>
      <email>kasprzak@ptkardio.pl</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Oddzia Kardio-angiologii ECZ Otwock</name>
      <address>
        <city>Otwock</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Adam Torbicki</last_name>
      <phone>+ 48 22 7103 052</phone>
      <email>adam.torbicki@ecz-otwock.pl</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Wojewódzki Szpital Specjalistyczny we Wrocawiu</name>
      <address>
        <city>Wrocaw</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jerzy Lewczuk</last_name>
      <phone>+48 71 32 70 530</phone>
      <email>lewczuk@wssk.wroc.pl</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>E.N.Meshalkin Novosibirsk State Research Institute Of Circulation Pathology Rosmedtechnology</name>
      <address>
        <city>Novosibirsk</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Alexander Chernyavskiy</last_name>
      <phone>+7 923 255 19 50</phone>
      <email>amchern@mail.ru</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Federal State Institution &quot;Federal center of Heart, Blood and Endocrinology named after V.A.Almazov Rosmedtekhnologies&quot;</name>
      <address>
        <city>St. Petersburg</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Olga Moiseeva</last_name>
      <phone>+7 812 702 68 16</phone>
      <email>omoiseeva@front.ru</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Federal State Budgetary Institution &quot;Research Institute for Cardiology&quot; of Siberian Branch under the Russian Academy of Medical Sciences / Cardiovascular Surgery Department</name>
      <address>
        <city>Tomsk</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sergey Popov</last_name>
      <phone>+7 3822 55 83 96</phone>
      <email>psv@cardio.tsu.ru</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Lung Infection &amp; Immunity Unit, Groote Schuur Hospital</name>
      <address>
        <city>Cape Town</city>
        <country>South Africa</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Keertan Dheda</last_name>
      <phone>+2721 406 6509</phone>
      <email>Keertan.dheda@uct.ac.za</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Chris Hani Baragwanath Hospital / Soweto Cardiovascular Research Unit, Division of Cardiology</name>
      <address>
        <city>Johannesburg</city>
        <country>South Africa</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Mohammed Rafique Essop</last_name>
      <phone>+27 11 933-8145</phone>
      <email>essopmr@medicine.wits.ac.za</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Pulmonology Division, Louis Pasteur Hospital</name>
      <address>
        <city>Pretoria</city>
        <country>South Africa</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Akhter Goolam-Mahomed</last_name>
      <phone>+27125215723</phone>
      <email>akhtergm@telkomsa.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire Vaudois</name>
      <address>
        <city>Lausanne</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>John-David Aubert</last_name>
      <phone>+41 21 314 13 76</phone>
      <email>john-david.aubert@chuv.ch</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital Zürich</name>
      <address>
        <city>Zürich</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Rudolf Speich</last_name>
      <phone>+41 44 255 22 01</phone>
      <email>Rudolf.speich@usz.ch</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>King Chulalongkorn Memorial Hospital, Division of Respiratory and Respiratory Critical Care Medicine</name>
      <address>
        <city>Bangkok</city>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Nattapong Jaimchariyatam</last_name>
      <phone>662-256-4252</phone>
      <email>drboy48@yahoo.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Siriraj Hospital, Division of Respiratory Disease and Tuberculosis</name>
      <address>
        <city>Bangkok</city>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Suree Sompradeekul</last_name>
      <phone>6681-499-3779</phone>
      <email>sisop@mahidol.ac.th</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>MAHARAJ NAKORN CHIANG MAI HOSPITAL, Department of Internal Medicine</name>
      <address>
        <city>Chiang Mai</city>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Arintaya Phrommintikul</last_name>
      <phone>6684-4262929</phone>
      <email>arintayap@yahoo.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Papworth Hospital NHS Trust, Pulmonary Vascular Diseases Unit</name>
      <address>
        <city>Cambridge</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Joanna Pepke-Zaba</last_name>
      <phone>01480 364627</phone>
      <email>Joanna.PepkeZaba@papworth.nhs.uk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hammersmith Hospital</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Luke Howard</last_name>
      <phone>020 3313 8078</phone>
      <email>l.howard@imperial.ac.uk</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
    <country>Austria</country>
    <country>Belgium</country>
    <country>Canada</country>
    <country>Chile</country>
    <country>Czech Republic</country>
    <country>France</country>
    <country>Germany</country>
    <country>Hungary</country>
    <country>Mexico</country>
    <country>Netherlands</country>
    <country>Poland</country>
    <country>Russian Federation</country>
    <country>South Africa</country>
    <country>Switzerland</country>
    <country>Thailand</country>
    <country>United Kingdom</country>
  </location_countries>
  <removed_countries>
    <country>China</country>
    <country>Bulgaria</country>
    <country>Italy</country>
  </removed_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 9, 2014</lastchanged_date>
  <firstreceived_date>December 20, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Chronic thromboembolic pulmonary hypertension (CTEPH)</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Hypertension, Pulmonary</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
